Wexner Medical Center, Ohio State University

Columbus, Ohio 43210

1 studies enrolling now · 4 studies all time

What they study most

Cancer, Post-Cardiac Arrest Syndrome

Studies at this site

• Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest — Starting soon
• Efficacy and Safety of SNX-5422 Added to an Established Dose of Ibrutinib in CLL — Stopped early
• Study of SNX-5422 in TP53 Null Cancers — Stopped early
• Safety and Activity of SNX-5422 Plus Ibrutinib in CLL — Withdrawn before enrolling